CA2931000A1 - Mitochondria-targeted dicarbonyl sequestering compounds - Google Patents

Mitochondria-targeted dicarbonyl sequestering compounds Download PDF

Info

Publication number
CA2931000A1
CA2931000A1 CA2931000A CA2931000A CA2931000A1 CA 2931000 A1 CA2931000 A1 CA 2931000A1 CA 2931000 A CA2931000 A CA 2931000A CA 2931000 A CA2931000 A CA 2931000A CA 2931000 A1 CA2931000 A1 CA 2931000A1
Authority
CA
Canada
Prior art keywords
formula
alkyl
compound
pharmaceutically acceptable
mitochondria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2931000A
Other languages
English (en)
French (fr)
Inventor
Michael Patrick Murphy
Robin Andrew James Smith
Richard Charles Hartley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United Kingdom Research and Innovation
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of CA2931000A1 publication Critical patent/CA2931000A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5442—Aromatic phosphonium compounds (P-C aromatic linkage)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Dentistry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
CA2931000A 2013-11-22 2014-11-21 Mitochondria-targeted dicarbonyl sequestering compounds Abandoned CA2931000A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1320636.2A GB201320636D0 (en) 2013-11-22 2013-11-22 Compounds
GB1320636.2 2013-11-22
PCT/EP2014/075323 WO2015075200A1 (en) 2013-11-22 2014-11-21 Mitochondria-targeted dicarbonyl sequestering compounds

Publications (1)

Publication Number Publication Date
CA2931000A1 true CA2931000A1 (en) 2015-05-28

Family

ID=49918047

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2931000A Abandoned CA2931000A1 (en) 2013-11-22 2014-11-21 Mitochondria-targeted dicarbonyl sequestering compounds

Country Status (12)

Country Link
US (1) US9963474B2 (enExample)
EP (2) EP3623375A1 (enExample)
JP (1) JP6661533B2 (enExample)
CN (1) CN105873936B (enExample)
AU (1) AU2014351802B2 (enExample)
CA (1) CA2931000A1 (enExample)
ES (1) ES2802123T3 (enExample)
GB (1) GB201320636D0 (enExample)
HK (1) HK1226079A1 (enExample)
SG (2) SG10201807904RA (enExample)
WO (1) WO2015075200A1 (enExample)
ZA (1) ZA201603129B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020503280A (ja) * 2016-12-29 2020-01-30 ウニヴェルシダージ ド ポルトＵｎｉｖｅｒｓｉｄａｄｅ Ｄｏ Ｐｏｒｔｏ ヒドロキシ安息香酸誘導体、その方法および使用
JP6985730B2 (ja) * 2017-11-17 2021-12-22 株式会社日立ハイテクサイエンス 試料分析システム、表示方法及び試料分析方法
KR101920902B1 (ko) * 2017-12-27 2018-11-21 전남대학교 산학협력단 심혈관 질환 조기진단 pet 조영용 화합물 및 그의 용도
WO2020036329A1 (ko) * 2018-08-16 2020-02-20 숙명여자대학교산학협력단 미토콘드리아 내 nad(p)h 검출을 위한 형광 프로브 및 이를 이용한 검출방법
AU2020212612B2 (en) * 2019-01-25 2025-07-31 Naji Abumrad Triphenylphosphonium-tethered salicylamine derivatives
EP3914077A4 (en) * 2019-01-25 2022-11-30 Vanderbilt University MITOCHONDRIAL TARGETING ISOKETAL/ISOLEVUGLANDIN SCAVENGERS
EP3925961A4 (en) * 2019-10-30 2022-05-11 Fusion Biotechnology Co., Ltd. Mitochondria-targeting compound and composition comprising same for treating or preventing aging-related diseases
WO2021154877A1 (en) * 2020-01-27 2021-08-05 Vanderbilt University Mitochondria-targeted isoketal/isolevuglandin scavengers and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB926998A (en) * 1960-04-25 1963-05-22 Ici Ltd New water-soluble azo dyestuffs containing phosphonium groups
JPS52806A (en) 1975-02-20 1977-01-06 Dai Ichi Kogyo Seiyaku Co Ltd Preparation of ester
JPS6029391B2 (ja) 1976-02-04 1985-07-10 富士写真フイルム株式会社 ベンゾトリアゾ−ル化合物
FR2776289B1 (fr) * 1998-03-20 2001-02-02 Oreal Composition de teinture d'oxydation contenant un coupleur cationique, procedes de teinture, nouveaux coupleurs cationiques
FR2776290B1 (fr) * 1998-03-20 2001-08-10 Oreal Nouveaux composes cationiques, leur utilisation comme coupleurs pour la teinture d'oxydation des fibres keratiniques, compositions tinctoriales et procedes de teinture
FR2788520B1 (fr) * 1999-01-19 2003-02-28 Oreal Nouveaux colorants mono-benzeniques cationiques, leur utilisation pour la teinture d'oxydation des fibres keratiniques, compositions tinctoriales et procedes de teinture
WO2002058659A1 (en) * 2001-01-23 2002-08-01 P&G-Clairol, Inc. Couplers for oxidative coloration of hair
AU2003258664A1 (en) * 2002-09-02 2004-03-19 Ciba Specialty Chemicals Holding Inc. Method of colouring porous material
JPWO2006059423A1 (ja) * 2004-12-02 2008-06-05 独立行政法人科学技術振興機構 過興奮性の細胞傷害によって生じる疾患を治療するための薬剤および方法
US7956193B2 (en) * 2007-05-04 2011-06-07 University Of South Florida Intramolecular C-H amination with sulfonyl azides
CA2699794C (en) 2007-09-10 2016-07-19 University Of Massachusetts Mitochondria-targeted anti-tumor agents
FR2984321A1 (fr) * 2011-12-16 2013-06-21 Oreal Paraphenylenediamines cationiques, composition comprenant au moins de tels composes, procede de mise en oeuvre et utilisation
CN102617467A (zh) * 2012-02-21 2012-08-01 大连理工大学 一种检测一氧化氮的超高灵敏荧光探针
FR2996552B1 (fr) * 2012-08-17 2016-10-14 Oreal Composition tinctoriale comprenant un derive o-alkyle substitue de meta-phenylenediamine cationique

Also Published As

Publication number Publication date
EP3623375A1 (en) 2020-03-18
AU2014351802B2 (en) 2019-10-03
WO2015075200A1 (en) 2015-05-28
CN105873936A (zh) 2016-08-17
GB201320636D0 (en) 2014-01-08
CN105873936B (zh) 2018-09-14
ZA201603129B (en) 2018-12-19
US20160289252A1 (en) 2016-10-06
AU2014351802A1 (en) 2016-05-26
ES2802123T3 (es) 2021-01-15
NZ719705A (en) 2021-09-24
EP3071582A1 (en) 2016-09-28
EP3071582B1 (en) 2020-04-29
HK1226079A1 (zh) 2017-09-22
US9963474B2 (en) 2018-05-08
JP6661533B2 (ja) 2020-03-11
SG10201807904RA (en) 2018-10-30
JP2017504561A (ja) 2017-02-09
SG11201603485TA (en) 2016-05-30

Similar Documents

Publication Publication Date Title
AU2014351802B2 (en) Mitochondria-targeted dicarbonyl sequestering compounds
CN102471248B (zh) 用于递送1,3-丙二磺酸的方法、化合物和组合物
JP6169076B2 (ja) 骨疾患の処置のためのヒストン脱アセチル化酵素６選択的阻害剤
ES2732230T3 (es) Compuestos que anulan el punto de control G2 del ciclo celular para una utilización en el tratamiento del cáncer
US9169214B2 (en) Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
ES2731657T3 (es) Derivados de ácido sulfónico, ácido fosfónico y ácido carboxílico que contienen amonio y su uso médico
RU2519948C2 (ru) Низкомолекулярные ингибиторы n-концевой активации рецептора андрогенов
JP7037597B2 (ja) クレアチンプロドラッグ、その組成物、及びその使用方法
IL296586A (en) Cyclophilin inhibitors and their uses
US12377084B2 (en) ERAP1 modulators
ES2712048T3 (es) Derivado de alquilamina
JP2026048875A (ja) インスリン耐性における使用方法のための治療化合物
JP2026041735A (ja) 治療用金属錯体およびリガンドならびにその作成および使用の方法
KR20200105833A (ko) 크레아틴 전구약물, 조성물과 이의 사용 방법
AU2019351731A1 (en) Spak kinase inhibitors as neuroprotective agents
JP7131878B2 (ja) Ｎ－メチル－ｄ－アスパラギン酸受容体アロステリックモジュレーター及びそれらの使用のための方法
TWI741979B (zh) 磷酸肌酸類似物前藥、其組成物及用途
NZ719705B2 (en) Mitochondria-targeted dicarbonyl sequestering compounds
ES2222988T3 (es) Formas de sal especificas de derivados de trifeniletileno como moduladores selectivos de los receptores de estrogenos.
BR112019026080A2 (pt) composições e métodos para modular o crescimento capilar
BR112018015851B1 (pt) Composto, e, medicamento

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20190906

FZDE Discontinued

Effective date: 20230721